1st Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$1,750,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 632 (114th), S. 1137 (114th), H.R. 9 (114th), S. 2019 (114th)

Health Issues HCR

Biosimilars, no specific bill Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill S. 1767, Combination Products Innovation Act of 2015 FDA Reform, H.R. 6, 21st Century Cures H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th), S. 1767 (114th), H.R. 3678 (114th)

Taxation/Internal Revenue Code TAX

International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
NANCY ELLEN MCCARTHY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1 (114th), H.R. 4900 (114th)

Medicare/Medicaid MMM

Medicare Part B (Average Sales Price) (Medicare Program Part B Drug Payment Model proposed rule) Medicare Part D drug reimbursement issues Coding and reimbursement for oncology drugs/biologics

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
RUTH HOFFMAN —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.